Scancell (LON:SCLP) Stock Passes Below Fifty Day Moving Average – Here’s What Happened

Scancell Holdings plc (LON:SCLP)’s stock price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 12.61 and traded as low as GBX 11. Scancell shares last traded at GBX 11.50, with a volume of 771,796 shares.

Scancell Trading Up 2.9%

The firm has a market capitalization of £122.80 million, a price-to-earnings ratio of -21.51 and a beta of 0.33. The company has a debt-to-equity ratio of -193.29, a quick ratio of 13.01 and a current ratio of 0.56. The company has a 50-day moving average price of GBX 12.56 and a 200-day moving average price of GBX 11.07.

Scancell (LON:SCLP) last announced its earnings results on Thursday, January 29th. The company reported GBX (0.55) earnings per share (EPS) for the quarter. Scancell had a negative net margin of 116.98% and a positive return on equity of 90.29%. As a group, research analysts forecast that Scancell Holdings plc will post -2.5361112 EPS for the current fiscal year.

Scancell Company Profile

Scancell (LSE:SCLP) is a clinical stage company leveraging two proprietary platforms, Immunobody® and Moditope®, to develop targeted off-the-shelf, patient-accessible active immunotherapies for a cancer-free future. The lead product iSCIB1+ is an Immunobody® DNA active immunotherapy that has demonstrated monotherapy activity in adjuvant melanoma. When combined with checkpoint therapies it showed additional clinical benefit over the checkpoints (CPI) alone in the ongoing Phase 2 SCOPE trial in advanced melanoma.